CB2 Insights Announces Q1 Financial Statements to be filed on or before July 14, 2020

NEXT STORY
The University of Texas Health Science Center at Houston joins Biomerica’s InFoods® Irritable Bowel Syndrome (“IBS”) Diagnostic-Guided Therapy (“DGT”) clinical trial
PREV STORY
Predictive Oncology Inc. Announces Receipt of Cash Proceeds of $2.2 Million from Exercise of Warrants
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AngioDynamics Announces Addition of New Board Members: Eileen Auen, Former Executive Chairman of Helios and Jan Stern Reed, Former General Counsel and Corporate Secretary at Walgreens Boots Alliance, Inc.

ALBANY, N.Y., Nov. 09, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of ...

author_avatar
NASDAQ Market News

Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Efficacy Endpoints in Second Successful Pivotal Phase 3 Clinical Trial for the Treatment of Common Warts (THWART-1)

author_avatar
NASDAQ Market News

Immunicum AB (publ) Provides Update on Ilixadencel Clinical Development Program

Press Release 3 April 2018 Immunicum AB (publ) Provides Update on Ilixadencel Clinical Development ...

author_avatar
NASDAQ Market News